All posts tagged "biotech"
-
1.5KBiotechIs Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) A Risky ‘Buy’ Investment?
Trend reversal appears to be in play, as Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) continues to bounce back after plunging to all-time lows late last...
-
2.0KBiotechAntibe Therapeutics Inc (OTCMKTS:ATBPF): A Potential Acquisition Target
Antibe Therapeutics Inc (OTCMKTS:ATBPF) is enjoying one of its best runs in the market, thanks to a string of positive news that...
-
2.8KBiotechPropanc Biopharma Inc (OTCMKTS:PPCB) Is Due For A Rebound
The recent stock performance of Propanc Biopharma Inc (OTCMKTS:PPCB) has not fulfilled the expectations of the market. Over the past year, the...
-
1.0KBiotechGuided Therapeutics Inc (OTCBB:GTHP) Makes Progress In Its Fight Against Cervical Cancer
Guided Therapeutics Inc (OTCBB:GTHP) has become a beacon in the global fight against cancer. The firm has had to battle against declining...
-
1.5KBiotechUS Stem Cell Inc (OTCMKTS:USRM) Still A Nice Recovery Play As Stem Cell Demand Explodes
US Stem Cell Inc (OTCMKTS:USRM) has lived up to expectations as a nice recovery play. Investors who took time to read our...
-
845BiotechRich Pharmaceuticals Inc (OTCMKTS:RCHA) is Relentless in its Bid to Overcome Cancer and Blood–Related Diseases
Rich Pharmaceuticals Inc (OTCMKTS:RCHA) is not in the best of places now. Since its peak of $0.0013 last year, it has been...
-
905BiotechPivot Pharmaceuticals Inc (OTCMKTS:PVOTF) On A Comeback Trail After Acquisition Spree
After spiking to record highs of $2.46 a share, Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) immediately felt the wrath of short sellers who triggered...
-
1.6KBiotechInMed Pharmaceuticals Inc (OTCMKTS:IMLFF) Rebounds In Style
InMed Pharmaceuticals Inc (OTCMKTS:IMLFF) is still on its way back up. Following the jump in its price to $1.89 and the subsequent...
-
1.6KBiotechPharmacyte Biotech Inc (OTCMKTS:PMCB) Announces Another Successful Study
In spite of the recent upturn in its fortunes, Pharmacyte Biotech Inc (OTCMKTS:PMCB) still has some work to do. After a major...
-
904BiotechWhat’s Next For Emisphere Technologies, Inc. (OTCMKTS:EMIS) As Financial Woes Kick In?
Late last year Emisphere Technologies, Inc. (OTCMKTS:EMIS) transitioned to a non-reporting company, a move that angered the markets triggering a selloff of...
